Sarah Speight

Articles by Sarah Speight

Biotech

UK universities prove resilience during Horizon hiatus

Although UK research universities were going strong after Horizon funding was pulled, it could have been a different story had the scheme not been reinstated, finds Sarah Speight.   14 September 2023

Pharma

Bausch Ireland fends off challenge to its cancer patent

Pharma firm fails to show evidence to prove obviousness in rival’s patent | Treatment can be used to treat cancer as well as ulcerative colitis and asthma.   12 September 2023

Pharma

‘One of the most positive announcements since Brexit’: UK lawyers react to new Horizon funding deal

The news that the UK will rejoin the €95.5 billion research fund has been met with widespread relief, but it’s a bittersweet story, finds Sarah Speight. Reaction from CMS, Arnold & Porter, Bird & Bird, HGF.   7 September 2023

Pharma

GSK targets Pfizer over newly approved RSV vaccine

GSK argues that its US rival knew of its patented technology seven years after research began | Blockbuster respiratory vaccines, world’s first of their kind, received US approval in May.   7 August 2023

article

Cooley appoints ‘first-rate’ life sciences partner trio

The ‘formidable’ three bring 52 years’ experience from Fish & Richardson collectively | ‘Extensive’ patent trial background includes branded Hatch-Waxman litigation.   6 June 2023

Pharma

Abbott sues former employee for alleged trade secrets theft

Ex-scientist faces lawsuit for allegedly downloading thousands of files before leaving for a rival | Abbott seeks damages for ‘flagrant misconduct’ brought to its attention by successive employer.   1 June 2023

Pharma

Moderna and Pfizer face fresh suits over COVID-19 vaccine

A US biotech is accusing the pair of infringing several of its “foundational” lipid particle patents | Pfizer and BioNTech accused plaintiff in earlier suit of antitrust in a dispute over one of the patents at issue.   30 May 2023

Pharma

Novartis ‘abused’ discovery process for Zolgensma patent

Two subsidiaries of the French pharma giant allege ‘wilful’ patent infringement by the Swiss-American pharma firm | Novartis ‘hid’ information in a previous lawsuit relating to spinal muscular atrophy drug used to treat young children.   23 May 2023

article

Teva loses plea against GSK’s $235m ‘skinny label’ win

The US Supreme Court knocks back Teva’s challenge to GSK’s damages win | Decision issued despite US solicitor general warning that the earlier decision ‘threatens significant harm’ to the market.   16 May 2023

article

AWA promotes female patent attorney to group CEO

The new CEO is currently Denmark CEO and group VP for the firm, who has ‘spearheaded international growth efforts’.   9 May 2023

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.